Oragenics Inc. 8-K Summary
Business Context and Reporting Period
Oragenics, Inc. filed this Current Report on Form 8-K on November 22, 2005, to disclose the entry into a material definitive agreement. The company is incorporated in Florida and is based in Alachua, Florida.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or total debt. The primary financial data relates to a specific financing transaction:
- Securities Issued: Up to 3,000,000 shares of common stock and 3,000,000 warrants.
- Stock Price: $0.40 per share.
- Warrant Exercise Price: $0.60 per share.
- Warrant Terms: Exercisable for two years; callable by the Company if the stock trades at or above $1.20 per share for 30 consecutive days.
- Expected Closing: On or before December 8, 2005.
Material Changes
The material change reported is the execution of a Securities Purchase Agreement with a group of private accredited investors on November 20, 2005. Additionally, the company entered into a Registration Rights Agreement requiring the filing of a registration statement for the resale of the purchased shares and warrant-issued shares. The filing references an amendment to the Company's loan agreement with its bank, though specific terms of that amendment are not detailed in this text.
Outlook, Risks, and Management Commentary
Management commentary is limited to the announcement of the financing. The offering is being made pursuant to an exemption from registration under Section 4(2) of the Securities Act of 1933. A press release dated November 21, 2005, is attached as Exhibit 99.1 and incorporated by reference. No specific forward-looking guidance or risk factors are detailed within the text of this 8-K.
Key Facts for Investor Verification
- Verify the final closing date of the private placement (expected by December 8, 2005).
- Review the attached press release (Exhibit 99.1) for details on the amendment to the bank loan agreement.
- Monitor the filing of the registration statement required by the Registration Rights Agreement.
- Confirm the total capital raised once the transaction closes.